Abbott raises sales expectations for Humira
January 21, 2004Abbott Laboratories has raised its sales forecast for Humira, its new rheumatoid arthritis treatment, to $700 million in 2004 after …
Pfizer to sell diagnostics business
January 21, 2004Pfizer has agreed to sell its Swedish in-vitro allergy and autoimmune diagnostic business to private equity groups Triton and PPM …
Aventis and Sanofi attempt to quash merger rumours
January 19, 2004Sanofi-Synthelabo and Aventis have been forced to officially deny they are in merger talks after speculation sent shares soaring in …
Streamlined research
January 19, 2004For many years the pharmaceutical industry has been promising that they were on the verge of a boom in the …
Sizing up med ed
January 19, 2004The use of medical education in the pharmaceutical industry has never been greater. Starting from the early stages of clinical …
Too close for comfort?
January 19, 2004Medical Communications, Sales and Marketing doctors, industry reputation
The pharmaceutical industry's increasing scale and influence means that no part of its conduct is above scrutiny, and criticism of …
Pfizer to sell-off sixty OTC products in Europe
January 16, 2004Pfizer is looking to sell off about 60 non-core consumer products in Europe to position the business for long-term growth …
Eloxatin approved in US as first line treatment
January 16, 2004Sanofi-Synthelabo's Eloxatin has received US approval for use as first line treatment of colorectal cancer in combination with standard treatment …
W.A.R marshals forces for healthcare push
January 16, 2004Independent marketing communications agency Ware Anthony Rust has consolidated its healthcare accounts into a new division prompted by the sector's …
Genzyme to set up research facility in UK
January 16, 2004Genzyme, one of the US' most successful biotechnology companies has chosen Cambridge as the location of its first research centre …
More states defy FDA warnings on re-imports
January 15, 2004A number of states and cities are drawing up plans to import medicines from Canada in open defiance of the …
New patient forums launch recruitment drive
January 8, 2004New bodies intended to give patients and the public a greater say in their local health service have been launched …
Exanta ready for launch across Europe
January 7, 2004AstraZeneca's new blockbuster candidate Exanta has been approved in France for the prevention of blood clots in major orthopaedic surgery.The …
Prescribing indicators included in PCT ratings overhaul
January 7, 2004The performance indicators used to calculate the star ratings of trusts in England have been given a major overhaul following …
Elan sells European sales and marketing business for $120 million
January 5, 2004Elan
Debt-laden Irish pharma company Elan has sold its European sales and marketing business to Medeus – a new pharma company …
Latest content
FibroFind appoints Lee Borthwick as CEO
